KUKJEON PHARMACEUTICAL Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-3,620	1,736	4,824	8,948	4,038
Depreciation & Amortization	5,219	5,105	3,134	1,444	1,106
Loss (Gain) From Sale of Assets	49.07	57.43	-	69.18	0
Loss (Gain) From Sale of Investments	-1,580	-1,831	-16.28	-373.28	-0.86
Loss (Gain) on Equity Investments	152.32	57.48	-1.15	4.35	276.83
Provision & Write-off of Bad Debts	1,630	13.63	-9.72	-3.06	113.92
Other Operating Activities	1,505	-558.93	2,130	-9,299	753.65
Change in Accounts Receivable	3,079	-102.16	-6,493	-2,128	-3,916
Change in Inventory	1,024	-105.88	-7,203	-3,541	-3,813
Change in Accounts Payable	-4,968	5,716	3,406	-670.22	5,448
Change in Other Net Operating Assets	849.69	-51.68	-115.82	-470.41	-964.89
Operating Cash Flow	3,340	10,036	-345.45	-6,019	3,042
Capital Expenditures	-3,175	-7,867	-43,923	-23,285	-10,409
Sale of Property, Plant & Equipment	0.73	0.73	-	2.09	-
Cash Acquisitions	3.96	-	-	295.92	-
Divestitures	-	-	441	-	-
Sale (Purchase) of Intangibles	-81.49	-3,622	-157.99	-482.07	-8.8
Investment in Securities	50,900	54,652	18,410	-53,176	-22,097
Other Investing Activities	345.7	-228.44	584.15	25.38	69.36
Investing Cash Flow	47,854	42,796	-24,314	-76,633	-32,579
Short-Term Debt Issued	-	10,911	35,734	101,363	27,327
Long-Term Debt Issued	-	42,827	8,000	18,562	-
Total Debt Issued	11,037	53,739	43,734	119,925	27,327
Short-Term Debt Repaid	-	-69,335	-28,338	-33,395	-33,653
Long-Term Debt Repaid	-	-914.41	-1,690	-933.22	-293.8
Total Debt Repaid	-61,987	-70,250	-30,028	-34,329	-33,947
Net Debt Issued (Repaid)	-50,950	-16,511	13,706	85,596	-6,620
Issuance of Common Stock	2,996	-	-	-	45,477
Repurchase of Common Stock	-	-	-	-	-1.03
Dividends Paid	-490.69	-490.69	-	-490.69	-
Other Financing Activities	-360	-	400	-5.6	-0
Financing Cash Flow	-48,805	-17,002	14,106	85,100	38,856
Foreign Exchange Rate Adjustments	1.39	0.69	-0.26	-0.34	0.13
Net Cash Flow	2,391	35,831	-10,554	2,447	9,320
Free Cash Flow	165.07	2,169	-44,269	-29,304	-7,367
Free Cash Flow Margin	0.12%	1.59%	-36.29%	-28.26%	-8.63%
Free Cash Flow Per Share	3.31	44.20	-902.17	-571.94	-167.01
Cash Interest Paid	1,432	1,682	1,373	771.53	238.65
Cash Income Tax Paid	499.34	746.06	-115.43	1,625	518.27
Levered Free Cash Flow	-19,668	-10,137	-40,786	-10,027	-
Unlevered Free Cash Flow	-15,847	-4,999	-37,202	-8,901	-
Change in Working Capital	-16.01	5,456	-10,406	-6,809	-3,245

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.